Remote sensing catheter system and methods

Information

  • Patent Grant
  • 9050400
  • Patent Number
    9,050,400
  • Date Filed
    Tuesday, August 12, 2008
    16 years ago
  • Date Issued
    Tuesday, June 9, 2015
    9 years ago
Abstract
A remote sensing catheter system including an injection catheter and a collection catheter. In one method of use, an external sensor of the system determines the timing of operation of the collection catheter. In another method of use, a sensor determines the volume of medium in the injection.
Description
FIELD OF THE TECHNOLOGY

The present disclosure relates generally to devices and systems for use in the medical field, and various methods associated with such devices and systems. More particularly, this disclosure relates to devices and systems used in medical procedures involving the removal of a medium from coronary circulation, and various methods associated therewith.


BACKGROUND

Coronary circulation is the circulation of blood in the vessels that supply blood to and from the heart muscle (the myocardium). The heart is supplied by the right and left coronary arteries and is drained mainly by veins that empty into the coronary sinus.


Angiography is a medical imaging technique in which an X-ray or fluoroscopic image is taken to visualize the lumen of blood vessels and organs of the body. To assist in the visualization process, a contrast media may be added to the blood.


One of the more common angiography procedures performed is the visualization of the coronary arteries. Typically in this procedure, a catheter is used to administer the contrast media into one of the two major coronary arteries. X-ray images of the contrast media within the blood allow visualization of the size, anatomy, and patency of the arterial vessels.


Contrast media, however, can have significant health risks if permitted to flow systemically to the patient's organs. For example, renal dysfunction or failure may occur from such systemic delivery of contrast media. Such dysfunction or failure is referred to as “contrast-induced nephropathy” or CIN.


Systems and methods have been developed for the removal of contrast media and other mediums from the coronary circulation. For example, in some removal methods, a removal catheter is positioned to collect medium as it exits the coronary circulation. In general, conventional systems used to collect and remove medium from the coronary circulation, and the associated conventional methods, can be improved.


SUMMARY

The present disclosure relates to a catheter system used in removing a medium from coronary circulation. In one aspect, the catheter system functions to determine the timing of removal, and is based upon a start time and a volume of an injection. In another aspect, the catheter system employs the use of at least one external sensor.


A variety of examples of desirable product features or methods are set forth in part in the description that follows, and in part will be apparent from the description, or may be learned by practicing various aspects of the disclosure. The aspects of the disclosure may relate to individual features as well as combinations of features, including combinations of features disclosed in separate embodiments. It is to be understood that both the foregoing general description and the following detailed description are explanatory only, and are not restrictive of the claimed invention.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a schematic representation of one embodiment of a sensing catheter system, in accordance with the principles disclosed;



FIG. 2 is a one time line illustrating operation of the sensing catheter system of FIG. 1;



FIG. 3 is a another time line illustrating operation of the sensing catheter system of FIG. 1;



FIG. 4 is a schematic representation of another embodiment of a sensing catheter system, in accordance with the principles disclosed; and



FIG. 5 is an enlarged view of a collection sensor of the sensing catheter system of FIG. 4.





DETAILED DESCRIPTION

Reference will now be made in detail to exemplary aspects of the present disclosure that are illustrated in the accompanying drawings. Wherever possible, the same reference numbers will be used throughout the drawings to refer to the same or like parts.


Contrast media is used to visualize the coronary vasculature as part of coronary diagnostic and therapeutic interventional procedures. The contrast media is toxic to the kidneys and may cause kidney impairment (contrast induced nephropathy), especially in patients with pre-existing kidney disease. Accordingly, contrast removal devices and procedures including catheters for the collection and removal of contrast have been developed. The procedures include inserting the catheter into the coronary sinus (the main vein draining the heart). As the injected contrast media passes through the heart and arrives in the coronary sinus, a negative pressure is applied to the catheter and the contrast mixed with blood is removed from the body. Continuous collection or removal of fluid from the coronary sinus can cause excessive blood loss. Therefore, timing of the removal is critical.


The present system and method relate to the timing of contrast removal from a vessel, such as the coronary sinus. In determining the most effective time for removal of contrast media from the coronary sinus, several events and/or factors are considered.


One factor is the transit time through the myocardium, from coronary artery to coronary sinus. Transit time has been studied in patients with normal and diseased coronary arteries. In the study, a marker solution was injected into the coronary artery; the arrival of the marker as well as the washout of the marker through the coronary sinus was monitored. The results of this study demonstrate that the transit time is relatively consistent for patients with normal coronary arteries. In particular, the marker arrived in the coronary sinus within two seconds after the start of a coronary arterial injection, and washed through the coronary sinus within an average of seven to eight seconds. Patients with obstructed coronary arteries exhibited similar transit time profiles, only with a slightly lengthened washout time. Other published studies as well as direct observations, show the transit time for contrast injected in the coronary arteries to arrive in the coronary sinus is within 4 to seconds. The longer transit time for contrast may be due to its increased viscosity. The present method and system utilizes this information to improve upon conventional methods of removing a medium from the coronary sinus.


Referring now to FIG. 1, a schematic representation of a remote sensing catheter system 10 for removing a medium from a patients' coronary circulation system is illustrated. It is to be understood that “medium” includes, for example, both contrast media and other non-contrast media, such as detection agents (e.g., saline). The system 10 generally includes an injection catheter 12, a collection catheter 14, and a vacuum or aspiration unit 16 that is in fluid communication with the collection catheter 14.


The system 10 further includes an injection sensor 18 and an interface unit 20. The interface unit 20 is electrically connected to both of the injection sensor 18 and the aspiration unit 16. During use, the interface unit 20 controls the operation of the collection catheter 14. What is meant by ‘controls the “operation” of collection catheter’ is that the interface unit 20 controls the activation and deactivation of the aspiration unit 16, which is in fluid communication with the collection catheter 14.


In some removal devices, a sensor is incorporated into a removal catheter and positioned internal to the coronary circulation system of the patient. The sensor is used to detect the arrival of contrast in a coronary vessel. Such internal sensors add significant complexity and cost into the design and manufacturing of the removal catheter. The present system provides a less complex and less costly design than that of systems having sensors placed within a patient's body during use. In particular, the injection sensor 18 of the present system 10 is remote, or located external to the patients' body during use of the system. In the illustrated embodiment, the injection sensor 18 is located between an injection syringe 22 and the injection catheter 12.


Referring still to FIG. 1, during use of the system 10, a distal end 24 of the injection catheter 12 is positioned within the patient's coronary artery. A distal end 26 of the collection catheter 14 is positioned within the patients' coronary sinus. In one method, the injection sensor 18 is then utilized to activation or start the removal and/or collection of a medium that has been injected into the patient's coronary artery through the injection catheter 12. Preferably, the removal starts at the time when the medium arrives in the coronary sinus to maximize the removal of the medium and minimize the removal of blood.


In particular, in the one method, the syringe 22 is used to inject the medium into the injection catheter 12. The injection of the medium is detected in the injection catheter 12 by way of the injection sensor 18 prior to the medium reaching the patient's coronary artery. The sensor 18 can include a pressure sensor, flow sensor, impedance sensor, or other sensor that detects or measures a specific parameter of an injection, or of the medium in the injection.


The sensor 18 establishes a start time of the injection. Operation of the collection catheter is then automatically initiated at a predetermined time after the start time of the injection. What is meant by “automatically” is that the operation is initiated by way of the interface unit 20, as opposed to manually initiating operation (i.e., manually activating the aspiration unit 16 and/or interface unit 20). The predetermined time after the start time of the injection typically includes a delay to account for the transit time of the medium so that operation of the collection catheter coincides with the arrival of the medium in the coronary sinus. Referring to FIGS. 2 and 3, in one method, the predetermined time after the start time (labeled Activation Interval) is about 2 to 6 seconds after the start time. In another method, the predetermined time is 4 to 6 seconds after the start time.


In general, the remote sensing catheter system 10 starts or initiates removal of a medium based on the timing from a coronary arterial injection. In addition to determining the timing for removal, the present system 10 can be used to determine whether or not the coronary arterial injection is of a significant amount to warrant activation of the system.


In particular, physicians commonly introduce a small dosage of medium (often referred to as a “puff”) into the coronary artery for evaluation purposes. The small puffs are sometimes introduced prior to a significant injection amount, and are sometimes introduced after a significant injection amount to evaluate the ongoing procedure. Collecting fluid from the coronary sinus after the injection of a puff is typically not recommended as more blood than medium is removed, which can lead to excessive blood loss depending upon the number of puffs employed during the procedure.


The present system 10 can be used to determine whether the injection is a puff of medium or a significant amount of medium that warrants removal. In particular, the injection sensor 18 can be used to determine the volume of medium in the injection. In one method, the interface unit 20 initiates operation of the collection catheter 14 only when the volume of medium in the injection is greater than a predetermined amount. Smaller volumes of medium (puffs) are ignored and operation of the collection catheter is not initiated.


In one embodiment, the determination of the volume of medium in the injection is based upon the duration of the injection. If the injection lasts longer than a predetermined duration parameter, then a significant injection amount is declared and operation of the collection catheter is initiated at the predetermined time. Referring to FIGS. 2 and 3, the duration of injection that defines a significant injection amount is defined by an injection duration that is greater than 1.5 seconds. As can be understood, the duration of the injection can end prior to initiating operation of the collection catheter (FIG. 2) or end after initiating operation of the collection catheter (FIG. 3).


The injection sensor 18 of the present system 10 can further be used to determine the timing of ceasing operation of the collection catheter 14. In such a method, the sensor 18 establishes an end time of the injection, as well as the start time. Operation of the collection catheter is then automatically ceased a predetermined time after the end time of the injection. What is meant by “automatically” is that the operation is ceased by way of the interface unit 20, as opposed to manually ceasing operation (i.e., manually deactivating the aspiration unit 16 and/or interface unit 20). Referring to FIGS. 2 and 3, in one method, the predetermined time after the end time (labeled Deactivation Interval) is about 4 to 10 seconds after the end time. Accordingly and in one method, operation of the collection catheter is initiated 2-6 seconds after the start time of the injection and ceases 4 to 10 seconds after the end time of the injection; the duration of operation of the collection catheter typically being between 4 to 6 seconds.


In an alternative embodiment, the timing of ceasing operation of the collection catheter 14 can be determined by use of a sensor. Referring now to FIG. 4, the remote sensing catheter system 10 includes a collection sensor 28 that can be used to cease operation of the collection catheter 14 after a desired majority of the medium has been removed from the coronary circulation. The interface unit 20 is electrically connected to the collection sensor 28 as well as the injection sensor 18 and the aspiration unit 16. The collection sensor 28 is remote, or located external to the patients' body during use of the system 10. The external collection sensor provides a less complex and less costly design than that of systems having internal sensors placed within a patient's body during use. In the illustrated embodiment, the collection sensor 28 is located between the collection catheter 14 and the aspiration unit 16.


The collection sensor 28 detects or senses the presence and/or absence of medium in the collection catheter 14. The sensor 28 can include an impedance sensor. Referring to FIGS. 4 and 5, in one embodiment, the sensor 28 includes an electrode array (e.g., x1, x2, x3) located within a disposal hub assembly 30 connected between a proximal end 32 of the collection catheter 14 and connection tubing 34 of the aspiration unit 16. Optical sensors, chemical sensors, density sensors, or other sensors that detect or measure a specific parameter of an injection or medium in the injection can also be used. In use, when the absence, for example, of the medium in the collection catheter 14 is detected, operation of the collection catheter is automatically ceased.


Still referring to FIG. 4, it is to be understood that alternative systems may include only the external collection sensor 28 (no injection sensor 18). In such a system, the physician would manually actuate operation of the collection catheter 14 a period of time, e.g., 2 to 3 seconds, after starting the injection. Likewise and referring to FIG. 1, in a system including only an external injection sensor, a physician can also manually cease operation of the collection catheter 14 a period of time after the end of the injection.


The above specification provides a complete description of the present invention. Since many embodiments of the invention can be made without departing from the spirit and scope of the invention, certain aspects of the invention reside in the claims hereinafter appended.

Claims
  • 1. A system that removes a coronary artery injection of medium from a coronary sinus, the system comprising: a) a collection catheter having a distal end positionable within a coronary sinus;b) an aspiration device in fluid communication with the collection catheter;c) an injection device;d) an injection catheter having a distal end positionable proximate a coronary artery;e) an injection sensor that cooperates with at least one of the injection device and the injection catheter, wherein the injection sensor is located proximate the injection catheter and external to a patient's body during use, and is adapted to detect an injection of a medium in the injection catheter; andf) an interface unit, the interface unit being electrically connected to the injection sensor and the aspiration device, wherein the interface unit: i) establishes a start time of the coronary artery injection of medium when the injection sensor detects the injection of the medium;ii) determines a significance of the volume of medium;iii) initiates aspiration by the aspirating unit to the collection catheter about 2 seconds to about 6 seconds after the start time of the injection, the initiation of operation occurring only if, and when, the volume of medium in the injection is determined to be significant; andiv) ceases operation of the aspiration unit to the collection catheter after about 4 seconds to about 10 seconds after a cessation of a significant injection.
  • 2. The system of claim 1, wherein the interface unit determines the significance of the volume of medium in the injection based upon a time duration of the injection.
  • 3. The system of claim 2, wherein the interface unit determines the significance of the volume of medium as corresponding to the time duration of the injection being at least one of and greater than 1.5 seconds.
  • 4. The system of claim 1, wherein during use, the injection sensor detects the injection prior to the injection of medium reaching the coronary artery.
  • 5. The system of claim 1, wherein the injection sensor is a pressure sensor.
  • 6. The system of claim 1, wherein the collection sensor is an impedance sensor.
  • 7. The system of claim 1, wherein the injection of medium is an injection of contrast media.
  • 8. The system of claim 1, wherein the injection sensor is part of the injection device.
US Referenced Citations (100)
Number Name Date Kind
3931815 Takatsuki Jan 1976 A
4054137 Lee et al. Oct 1977 A
4581017 Sahota Apr 1986 A
4592341 Omagari et al. Jun 1986 A
4795427 Helzel Jan 1989 A
4838872 Sherlock Jun 1989 A
4969470 Mohl et al. Nov 1990 A
5069662 Bodden Dec 1991 A
5338662 Sadri Aug 1994 A
5423745 Todd et al. Jun 1995 A
5494822 Sadri Feb 1996 A
5807311 Palestrant Sep 1998 A
5807318 St. Goar et al. Sep 1998 A
5807322 Lindsey et al. Sep 1998 A
5810757 Sweezer, Jr. et al. Sep 1998 A
5813842 Tamari Sep 1998 A
5871464 Tryggvason et al. Feb 1999 A
5871465 Vasko Feb 1999 A
6021340 Randolph et al. Feb 2000 A
6080170 Nash et al. Jun 2000 A
6093392 High et al. Jul 2000 A
6110139 Loubser Aug 2000 A
6152141 Stevens et al. Nov 2000 A
6186146 Glickman Feb 2001 B1
6251093 Valley et al. Jun 2001 B1
6254563 Macoviak et al. Jul 2001 B1
6295990 Lewis et al. Oct 2001 B1
6342214 Tryggvason et al. Jan 2002 B1
6376471 Lawrence, III et al. Apr 2002 B1
6398752 Sweezer et al. Jun 2002 B1
6481439 Lewis et al. Nov 2002 B1
6500158 Ikeguchi Dec 2002 B1
6508777 Macoviak et al. Jan 2003 B1
6554819 Reich Apr 2003 B2
6558349 Kirkman May 2003 B1
6569147 Evans et al. May 2003 B1
6585716 Altman Jul 2003 B2
6595963 Barbut Jul 2003 B1
6638264 Tryggvason et al. Oct 2003 B1
6638268 Niazi Oct 2003 B2
6673039 Bridges et al. Jan 2004 B1
6689090 Tryggvason et al. Feb 2004 B1
6699231 Sterman et al. Mar 2004 B1
6726651 Robinson et al. Apr 2004 B1
6935344 Aboul-Hosn et al. Aug 2005 B1
6980843 Eng et al. Dec 2005 B2
6992070 Donahue et al. Jan 2006 B2
7211073 Fitzgerald et al. May 2007 B2
7300429 Fitzgerald et al. Nov 2007 B2
7331922 Mohl Feb 2008 B2
7363072 Movahed Apr 2008 B2
7722596 Shapland et al. May 2010 B2
8152786 Shapland et al. Apr 2012 B2
20010052345 Niazi Dec 2001 A1
20020062121 Tryggvason et al. May 2002 A1
20020077595 Hundertmark et al. Jun 2002 A1
20020091349 Reich Jul 2002 A1
20020099254 Movahed Jul 2002 A1
20020107504 Gordon Aug 2002 A1
20020165598 Wahr et al. Nov 2002 A1
20020169436 Gurm et al. Nov 2002 A1
20030138350 Macoviak Jul 2003 A1
20030163081 Constantz et al. Aug 2003 A1
20030191434 Dorros et al. Oct 2003 A1
20030236533 Wilson et al. Dec 2003 A1
20040002159 Xiao et al. Jan 2004 A1
20040030286 Altman Feb 2004 A1
20040099596 Naghavi et al. May 2004 A1
20040102732 Naghavi et al. May 2004 A1
20040102766 Poleo, Jr. May 2004 A1
20040210239 Nash et al. Oct 2004 A1
20040254523 Fitzgerald et al. Dec 2004 A1
20050010189 Toomey et al. Jan 2005 A1
20050124969 Fitzgerald et al. Jun 2005 A1
20050192548 Dolliver et al. Sep 2005 A1
20050197531 Cabiri et al. Sep 2005 A1
20050226855 Alt et al. Oct 2005 A1
20050256441 Lotan et al. Nov 2005 A1
20050273014 Gianchandani et al. Dec 2005 A1
20060013772 LeWinter et al. Jan 2006 A1
20070078352 Pijls Apr 2007 A1
20070118072 Nash May 2007 A1
20070203445 Kaye et al. Aug 2007 A1
20070255162 Abboud et al. Nov 2007 A1
20080021314 Movahed Jan 2008 A1
20080108960 Shapland et al. May 2008 A1
20080125698 Gerg et al. May 2008 A1
20080125746 Shapland et al. May 2008 A1
20080306425 Al-Rashdan Dec 2008 A1
20090018526 Power Jan 2009 A1
20090069829 Shturman Mar 2009 A1
20090187131 Fitzgerald et al. Jul 2009 A1
20090234321 Shapland et al. Sep 2009 A1
20100041984 Shapland et al. Feb 2010 A1
20100082004 Shapland et al. Apr 2010 A1
20100168564 Shapland et al. Jul 2010 A1
20100274173 Shapland et al. Oct 2010 A1
20110015558 Kaye et al. Jan 2011 A1
20110172558 Shapland et al. Jul 2011 A1
20130079697 Kaye Mar 2013 A1
Foreign Referenced Citations (31)
Number Date Country
10102045 Jan 2003 DE
0 301 854 Feb 1989 EP
0 150 960 Jan 1990 EP
0 526 102 Apr 1998 EP
1859826 Nov 2007 EP
2 125 487 Mar 1984 GB
2001 526071 Dec 2001 JP
WO 8901309 Feb 1989 WO
WO 9220387 Nov 1992 WO
WO 9831405 Jul 1998 WO
WO 9856440 Dec 1998 WO
WO 9906097 Feb 1999 WO
WO 9929227 Jun 1999 WO
WO 9930765 Jun 1999 WO
WO 9931982 Jul 1999 WO
WO 0100268 Jan 2001 WO
WO 0113983 Mar 2001 WO
WO 0183004 Nov 2001 WO
WO 0197901 Dec 2001 WO
WO 02060511 Aug 2002 WO
WO 02087677 Nov 2002 WO
WO 03070330 Aug 2003 WO
WO 2004083817 Sep 2004 WO
WO 2005027995 Mar 2005 WO
WO 2005082440 Sep 2005 WO
WO 2006004882 Jan 2006 WO
WO 2006004882 Jan 2006 WO
WO 2006042219 Apr 2006 WO
WO 2007002154 Jan 2007 WO
WO 2007143288 Dec 2007 WO
WO 2008122048 Oct 2008 WO
Non-Patent Literature Citations (14)
Entry
Texas heart Institute Journal; Transcatheter Coronary Artery Diagnostic Techniques, vol. 16, No. 3, dated: 1989; 9 pgs.
Alfayoumi, F. et al., The No-Reflow Phenomenon: Epidemiology, Pathophysiology and Therapeutic Approach, Review in Cardiovascular Medicine, vol. 6, No. 2, (2005); pp. 72-83.
Assali, A. et al., “Intracoronary Adenosine Administered During Precutaneous Intervention in Acute Myocardial Infarction and Reduction in the Incidence of “No Reflow” Phenomenon”, Catheterization and Cardiovascular Interventions, vol. 51 (2000); pp. 27-31.
De Lentos, J. et al., “New Tools for Assessing Microvascular Obstructions in Patients with ST Elevation Myocardial Infarction”, Heart, vol. 90, (2004); pp. 119-120.
Kramer, C., “The Prognostic Significance of Microvascular Obstruction After Myocardial Infarction as Defined by Cardiovascular Magnetic Resonance”, European Heart Journal, vol. 26, (2005): pp. 532-533.
Marzilli, M et al., “Primary Coronary Angioplasty in Acute Myocardial Infarction: Clincial Correlates of he “No Reflow” Phenomenon”, International Journal of Cardiology, vol. 65 (Suppl. 1) (1998); pp. S23-S28.
Michishita et al., “A Novel Contrast Removal System from the Coronary Sinus Using an Absorbing Column During Coronary Angiogaphy in a Porcine Model”, Journal of the American College of Cardiology, vol. 47, No. 9, 2006; 6 pages.
Resnic, F. et al., “No-Reflow is an independent Predictor of Death and Myocardial Infarction after Percutaneous Coronary Intervention”, American Heart Journal, vol. 145, No. 1, (2003); pp. 42-46.
Schräder, “Contrast: Media-Induced Renal Failure: An Overview”, Journal of Interventional Cardiology, vol. 18, No. 6; (2005); pp. 417-423.
del Monte et al., “Improvement in Survival and Cardiac Metabolism After Gene Transfer of Sarcoplasmic Reticulum CA2+-ATPase in a Rat Model of Heart Failure”, Circulation, 104(12): 1424-1429, 2001.
Hajjar et al., “Modulation of Ventricular Function Through Gene Transfer in Vivo”, Proc. Natl. Acad. Sci., USA, 95: 5251-5256, 1998.
Logeart, D. et al., “How to Optimize In Vivo Gene Transfer to Cardiac Myocyotes: Mechanical or Pharmacological Procedures?”, Human Gene Therapy, 12: 1601-1610, 2001.
PCT International Search Report and Written Opinion in Application PCT/US2009/051336, mailed Feb. 19, 2010, 13 pgs.
Fried, Steven et al., “Safe, compact and portable system for regional chemotherapeutic hyperthermic perfusion procedures”, Journal of Extra-corporeal Technology, vol. 25, No. 1, pp. 22-26 (1993).
Related Publications (1)
Number Date Country
20100042069 A1 Feb 2010 US